Product Information

OLOPATADINE HCL 0.2% EYE DROP is a generic product labeled by Chain Drug Marketing Association, priced at $2.9954 per ML under NDC 83324012025. Its NADAC has been published 74 times since Jan 29, 2025.

The High Outlier badge above means this manufacturer's average price in the Olopatadine Hydrochloride Ophthalmic market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

OLOPATADINE HCL 0.2% EYE DROP

Olopatadine Hydrochloride Ophthalmic
$2.9954per ML
High Outlier
OTC

Strength

2 mg/mL

NDC

83324012025

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Last Updated

6/17/2026

Active Ingredients

OLOPATADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209752

On Market Since

1/1/2021

Pharmacological Classes

Decreased Histamine Release
Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist
Histamine-1 Receptor Inhibitor
Mast Cell Stabilizer

Price Statistics

The NADAC for OLOPATADINE HCL 0.2% EYE DROP has been published 74 times since Jan 29, 2025, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.9954 per ML
All-time high$3.7687 (Mar 12, 2025)
All-time low$2.9954 (Jun 17, 2026)
52-week high$3.6822
52-week low$2.9954
Median price$3.5166
Average price$3.4774
Largest weekly change-5.7% (Apr 23, 2025)
Weeks tracked74
Tracking sinceJan 29, 2025

Price History

1W

0.0%

1M

-3.3%

3M

-8.2%

6M

-11.8%

1Y

-14.0%

3Y

N/A

5Y

N/A

All

-18.7%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OLOPATADINE HCL 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.2% EYE DROP, manufactured by Chain Drug Marketing Association, is $2.9954 per ML (NDC 83324012025), effective Jun 24, 2026.

How has the price of OLOPATADINE HCL 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has declined 18.7%. It has been tracked across 74 weekly CMS publications since Jan 29, 2025.

What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.2% EYE DROP?

Since Jan 29, 2025, the NADAC for OLOPATADINE HCL 0.2% EYE DROP has ranged from a low of $2.9954 (Jun 17, 2026) to a high of $3.7687 (Mar 12, 2025), with a median of $3.5166 per ML.

Are there cheaper alternatives to OLOPATADINE HCL 0.2% EYE DROP?

5 NADAC-published products share the same active ingredient, strength, and dosage form as OLOPATADINE HCL 0.2% EYE DROP, but none are currently priced below it.

Who manufactures OLOPATADINE HCL 0.2% EYE DROP?

OLOPATADINE HCL 0.2% EYE DROP (NDC 83324012025) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.